Activation of epidermal growth factor receptor mediates reperfusion arrhythmias in anaesthetized rats

Cardiovascular Research

Volumn 93, Issue 1, 2012, Pages 60-68

  Feng, Mei ^a,b   Xiang, Ji Zhou ^a   Ming, Zhang Yin ^a   Fu, Qin ^a   Ma, Rong ^a   Zhang, Qiu Fang ^c   Dun, Yao Yan ^a   Yang, Lei ^d   Liu, Hui ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c HUBEI UNIVERSITY OF MEDICINE   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Epidermal growth factor receptor; Reperfusion arrhythmias; Tyrosine phosphorylation of ion channels

Indexed keywords

CALCIUM CHANNEL L TYPE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; KV4.2 CHANNEL; N (4 BUTYLPHENYL) ALPHA CYANOCAFFEIC ACID AMIDE; SHAL POTASSIUM CHANNEL; SODIUM CHANNEL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CORONARY ARTERY LIGATION; GENE SILENCING; HEART ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; ISCHEMIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MUSCLE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION;

ANIMALS; ARRHYTHMIAS, CARDIAC; BASE SEQUENCE; CALCIUM CHANNELS, L-TYPE; MALE; MYOCARDIAL REPERFUSION INJURY; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; RNA, SMALL INTERFERING; SODIUM CHANNELS; TYRPHOSTINS;

EID: 84555177779     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr281     Document Type: Article

References (51)

1. Moens AL, Claeys MJ, Timmermans JP, Vrints CJ. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int J Cardiol 2005;100:179-190.
2. Kukreja RC, Janin Y. Reperfusion injury: basic concepts and protection strategies. J Thromb Thrombolysis 1997;4:7-24. (Pubitemid 27087182)
3. Ferdinandy P, Schulz R, Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 2007;59:418-458.
4. Manning AS, Hearse DJ. Reperfusion-induced arrhythmias: mechanisms and prevention. J Mol Cell Cardiol 1984;16:497-518. (Pubitemid 15040732)
5. Ferrier GR, Moffat MP, Lukas A. Possible mechanisms of ventricular arrhythmias elicited by ischemia followed by reperfusion. Studies on isolated canine ventricular tissues. Circ Res 1985;56:184-194. (Pubitemid 15131380)
6. Pogwizd SM, Corr PB. Electrophysiologic mechanisms underlying arrhythmias due to reperfusion of ischemic myocardium. Circulation 1987;76:404-426. (Pubitemid 17127013)
7. Amerini S, Carbonin P, Cerbai E, Giotti A, Mugelli A, Pahor M. Electrophysiological mechanisms for the antiarrhythmic action of mexiletine on digitalis-, reperfusionand reoxygenation-induced arrhythmias. Br J Pharmacol 1985;86:805-815. (Pubitemid 16211357)
8. Holbro T, Hynes NE. ErbB receptors: directing key signaling networks throughout life. Annu Rev Pharmacol Toxicol 2004;44:195-217. (Pubitemid 38263839)
9. Johnston JB, Navaratnam S, Pitz MW, Maniate JM, Wiechec E, Baust H et al. Targeting the EGFR pathway for cancer therapy. Curr Med Chem 2006;13:3483-3492. (Pubitemid 44873742)
10. Zhai P, Galeotti J, Liu J, Holle E, Yu X, Wagner T et al. An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy. Circ Res 2006;99:528-536. (Pubitemid 44337825)
11. Iwamoto R, Mekada E. ErbB and HB-EGF signaling in heart development and function. Cell Struct Funct 2006;31:1-14.
12. Kagiyama S, Eguchi S, Frank GD, Inagami T, Zhang YC, Phillips MI. Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense. Circulation 2002;106:909-912. (Pubitemid 34925322)
13. Greiser M, Halaszovich CR, Frechen D, Boknik P, Ravens U, Dobrev D et al. Pharmacological evidence for altered src kinase regulation of I (Ca,L) in patients with chronic atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol 2007;375:383-392. (Pubitemid 47087500)
14. Dubuis E, Rockliffe N, Hussain M, Boyett M, Wray D, Gawler D. Evidence for multiple Src binding sites on the alpha1c L-type Ca2+ channel and their roles in activity regulation. Cardiovasc Res 2006;69:391-401. (Pubitemid 43098795)
15. Gao Z, Lau CP, Wong TM, Li GR. Protein tyrosine kinase-dependent modulation of voltage-dependent potassium channels by genistein in rat cardiac ventricular myocytes. Cell Signal 2004;16:333-341. (Pubitemid 37542408)
16. Tiran Z, Peretz A, Attali B, Elson A. Phosphorylation-dependent regulation of Kv2.1 channel activity at tyrosine 124 by Src and by protein-tyrosine phosphatase epsilon. J Biol Chem 2003;278:17509-17514. (Pubitemid 36799638)
17. Zhang DY, Wang Y, Lau CP, Tse HF, Li GR. Both EGFR kinase and Src-related tyrosine kinases regulate human ether-a-go-go-related gene potassium channels. Cell Signal 2008;20:1815-1821.
18. Liu H, Sun HY, Lau CP, Li GR. Regulation of voltage-gated cardiac sodium current by epidermal growth factor receptor kinase in guinea pig ventricular myocytes. J Mol Cell Cardiol 2007;42:760-768. (Pubitemid 46546391)
19. Zhang Q, Xiang J, Wang X, Liu H, Hu B, Feng M et al. Beta(2)-adrenoceptor agonist clenbuterol reduces infarct size and myocardial apoptosis after myocardial ischaemia/reperfusion in anaesthetized rats. Br J Pharmacol 2010;160:1561-1572.
20. Walker MJ, Curtis MJ, Hearse DJ, Campbell RW, Janse MJ, Yellon DM et al. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res 1988;22:447-455.
21. Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 2007;13:486-491. (Pubitemid 46559834)
22. Curtis MJ, Walker MJ. Quantification of arrhythmias using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischaemia. Cardiovasc Res 1988;22:656-665.
23. Kitsis RN, Buttrick PM, McNally EM, Kaplan ML, Leinwand LA. Hormonal modulation of a gene injected into rat heart in vivo. Proc Natl Acad Sci USA 1991;88:4138-4142. (Pubitemid 21914494)
24. Sarkar N, Blomberg P, Wardell E, Eskandarpour M, Sylven C, Drvota V et al. Nonsurgical direct delivery of plasmid DNA into rat heart: time course, dose response, and the influence of different promoters on gene expression. J Cardiovasc Pharmacol 2002;39:215-224. (Pubitemid 34093541)
25. Zhang XH, Li GR, Bourreau JP. The effect of adrenomedullin on the L-type calcium current in myocytes from septic shock rats: signaling pathway. Am J Physiol Heart Circ Physiol 2007;293:H2888-H2893.
26. Garcia-Rivas GJ, Carvajal K, Correa F, Zazueta C. Ru360, a specific mitochondrial calcium uptake inhibitor, improves cardiac post-ischaemic functional recovery in rats in vivo. Br J Pharmacol 2006;149:829-837. (Pubitemid 44851707)
27. Woodward B, Zakaria MN. Effect of some free radical scavengers on reperfusion induced arrhythmias in the isolated rat heart. J Mol Cell Cardiol 1985;17:485-493. (Pubitemid 15000345)
28. Ogura T, Shuba LM, McDonald TF. L-type Ca2+ current in guinea pig ventricular myocytes treated with modulators of tyrosine phosphorylation. Am J Physiol 1999; 276:H1724-H1733. (Pubitemid 29246562)
29. Mitsudomi T, Yatabe Y. Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer. FEBS J 2010;277:301-308.
30. Melenhorst WB, Mulder GM, Xi Q, Hoenderop JG, Kimura K, Eguchi S et al. Epidermal growth factor receptor signaling in the kidney: key roles in physiology and disease. Hypertension 2008;52:987-993.
31. Matrougui K. Diabetes and microvascular pathophysiology: role of epidermal growth factor receptor tyrosine kinase. Diabetes Metab Res Rev 2010;26:13-16.
32. Yano T, Yazima S, Hagiwara K, Ozasa H, Ishizuka S, Horikawa S. Activation of epidermal growth factor receptor in the early phase after renal ischemia-reperfusion in rat. Nephron 1999;81:230-233. (Pubitemid 29080436)
33. Usul H, Cakir E, Cobanoglu U, Alver A, Peksoylu B, Topbas M et al. The effects of tyrphostine Ag 556 on experimental spinal cord ischemia reperfusion injury. Surg Neurol 2004;61:45-54. (Pubitemid 38056578)
34. Rajan S, Radhakrishnan J, Rajamanickam C. Direct injection and expression in vivo of full-length cDNA of the cardiac isoform of alpha-2 macroglobulin induces cardiac hypertrophy in the rat heart. Basic Res Cardiol 2003;98:39-49. (Pubitemid 36163516)
35. Weig HJ, LaugwitzKL, Moretti A, Kronsbein K, Stadele C, Bruning S et al. Enhanced cardiac contractility after gene transfer of V2 vasopressin receptors in vivo by ultrasound-guided injection or transcoronary delivery. Circulation 2000;101:1578-1585. (Pubitemid 30180895)
36. Lorita J, Soley M, Ramirez I. Epidermal growth factor protects the heart against low-flow ischemia-induced injury. J Physiol Biochem 2010;66:55-62.
37. Forster K, Kuno A, Solenkova N, Felix SB, Krieg T. The delta-opioid receptor agonist DADLE at reperfusion protects the heart through activation of pro-survival kinases via EGF receptor transactivation. Am J Physiol Heart Circ Physiol 2007;293:H1604-H1608. (Pubitemid 47367206)
38. Philipp S, Critz SD, Cui L, Solodushko V, Cohen MV, Downey JM. Localizing extracellular signal-regulated kinase (ERK) in pharmacological preconditioning's trigger pathway. Basic Res Cardiol 2006;101:159-167. (Pubitemid 43250808)
39. Nayler WG. The heart cell: some metabolic aspects of cardiac arrhythmias. Acta Med Scand Suppl 1981;647:17-31. (Pubitemid 11058779)
40. Davis MJ, Wu X, Nurkiewicz TR, Kawasaki J, Gui P, Hill MA et al. Regulation of ion channels by protein tyrosine phosphorylation. Am J Physiol Heart Circ Physiol 2001; 281:H1835-H1862.
41. Levitan IB. Modulation of ion channels by protein phosphorylation and dephosphorylation. Annu Rev Physiol 1994;56:193-212. (Pubitemid 24111859)
42. Peppelenbosch MP, Tertoolen LG, de Laat SW. Epidermal growth factor-activated calcium and potassium channels. J Biol Chem 1991;266:19938-19944. (Pubitemid 21908409)
43. Arh M, Budihna MV. Comparison of effects of nitrendipine, lacidipine and mibefradil on postischaemic myocardial damage in isolated rat hearts. Pflugers Arch 2000;440: R149-R150.
44. Su MJ, Chang GJ, Wu MH, Kuo SC. Electrophysiological basis for the antiarrhythmic action and positive inotropy of HA-7, a furoquinoline alkaloid derivative, in rat heart. Br J Pharmacol 1997;122:1285-1298.
45. Nearing BD, Hutter JJ, Verrier RL. Potent antifibrillatory effect of combined blockade of calcium channels and 5-HT2 receptors with nexopamil during myocardial ischemia and reperfusion in dogs: comparison to diltiazem. J Cardiovasc Pharmacol 1996;27: 777-787. (Pubitemid 26171689)
46. Josephson IR, Brown AM. Inwardly rectifying single-channel and whole cell K+ currents in rat ventricular myocytes. J Membr Biol 1986;94:19-35. (Pubitemid 17048141)
47. Nerbonne JM, Kass RS. Molecular physiology of cardiac repolarization. Physiol Rev 2005;85:1205-1253. (Pubitemid 41362269)
48. Rees S, Curtis MJ. Which cardiac potassium channel subtype is the preferable target for suppression of ventricular arrhythmias? Pharmacol Ther 1996;69: 199-217. (Pubitemid 26176623)
49. Manning AS, Coltart DJ, Hearse DJ. Ischemia and reperfusion-induced arrhythmias in the rat. Effects of xanthine oxidase inhibition with allopurinol. Circ Res 1984;55: 545-548. (Pubitemid 15201919)
50. Wu D, Stassen JM, Seidler R, Doods H. Effects of BIIB513 on ischemia-induced arrhythmias and myocardial infarction in anesthetized rats. Basic Res Cardiol 2000; 95:449-456.
51. Ando M, Katare RG, Kakinuma Y, Zhang D, Yamasaki F, Muramoto K et al. Efferent vagal nerve stimulation protects heart against ischemia-induced arrhythmias by preserving connexin43 protein. Circulation 2005;112:164-170. (Pubitemid 40982297)